Literature DB >> 30242482

Synthetic Opioids.

Patrick M Beardsley1, Yan Zhang2.   

Abstract

Opioid abuse has been a global menace for centuries, but the proliferation of synthetic opioids and their use within this current decade have created epidemic-level harms in some countries. According to the United Nations Office on Drugs and Crime, almost 12 million years were estimated loss of "healthy" life resulting in premature death and disability attributable to global opioid abuse just in 2015. Law enforcement and regulatory authorities have been particularly challenged abating the spread of synthetic opioids because soon after controlling the currently recognized abused opioids, their structures are tweaked, and new entities replace them. Drug racketeers have most often exploited the fentanyl phenylpiperidine structure in this regard, but non-fentanyl-like and classical morphinan-like structures have been pirated as well. A growing number of anecdotal reports identify respiratory depression induced by these newer synthetic opioids to be especially refractive to reversal by antagonists, with consequently high levels of lethality. This review examines three of these synthetic opioids representing three chemical classes (U-47700, MT-45, and acetylfentanyl) that have emerged to be of such menace that they have been brought under international control in recent years and addresses factors that could make synthetic opioids especially untreatable by opioid antagonists.

Entities:  

Keywords:  Acetylfentanyl; MT-45; NPS; Opioid; Synthetic opioid; U-47700

Mesh:

Substances:

Year:  2018        PMID: 30242482     DOI: 10.1007/164_2018_149

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  6 in total

1.  Frequently asked questions about naloxone: Part 3.

Authors:  Ashley Cid; Alec Patten; Kelly Grindrod; Michael A Beazely
Journal:  Can Pharm J (Ott)       Date:  2021-11-05

2.  Analgesic and Sedative Effects of Different Doses of Dexmedetomidine Combined with Butorphanol in Continuous Analgesia after a Cesarean Section.

Authors:  Hui Liu; Yalin Wang; Fulong Li; Wei Ren; Li Yuan
Journal:  Front Surg       Date:  2022-05-04

3.  Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario.

Authors:  Davide Arillotta; Fabrizio Schifano; Flavia Napoletano; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Eugenio Aguglia; Alessandro Vento
Journal:  Front Neurosci       Date:  2020-03-18       Impact factor: 4.677

Review 4.  An Update on the Implications of New Psychoactive Substances in Public Health.

Authors:  Ana Y Simão; Mónica Antunes; Emanuel Cabral; Patrik Oliveira; Luana M Rosendo; Ana Teresa Brinca; Estefânia Alves; Hernâni Marques; Tiago Rosado; Luís A Passarinha; Maristela Andraus; Mário Barroso; Eugenia Gallardo
Journal:  Int J Environ Res Public Health       Date:  2022-04-17       Impact factor: 4.614

5.  Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.

Authors:  Tanja M Gampfer; Lea Wagmann; Yu Mi Park; Annelies Cannaert; Jennifer Herrmann; Svenja Fischmann; Folker Westphal; Rolf Müller; Christophe P Stove; Markus R Meyer
Journal:  Arch Toxicol       Date:  2020-04-05       Impact factor: 5.153

Review 6.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.